Replacing a superstar can be difficult, except for the uber talented. Case in point: the Green Bay Packers’ Aaron Rodgers stepping in at quarterback for Brett Favre and not missing a beat.
In the pharma arena, Alexion’s blossoming rare disease standout Ultomiris is showing it has the right stuff to take the reins from aging mainstay Soliris.
Thursday, Ultomiris continued its rapid ascent with an FDA approval to treat generalized myasthenia gravis (gMG), an autoimmune neuromuscular disorder that causes severe weakness and loss of muscle function.
